Does SLE Increase the Risk for Perioperative Major Adverse Cardiovascular Events?
Future research should look to improve perioperative management in people with systemic lupus erythematosus.
Cardiovascular and Metabolic Disorders
Examining the Implications of Accelerated Coronary Plaque Formation in Psoriatic Arthritis
Disease severity and activity in psoriatic arthritis may predict coronary plaque burden better than traditional risk factors.
Cardiovascular Disease Risk in Patients With Systemic Lupus Erythematosus
Improved treatment in SLE with increased life expectancy has been accompanied by an elevated risk for developing cardiovascular diseases.
Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels
Following adjustment, fracture risk was highest among patients in the lowest osteoprotegerin levels.
Psoriasis Patients Have Higher Cardiometabolic Comorbidity Rates
Psoriasis patients have high rates hyperlipidemia, hypertension, depression, type 2 diabetes mellitus, and obesity.
Arterial Function in Patients With RA Consistently Associated With Cardiovascular Risk Factors
Researchers found that traditional cardiovascular risk factors and disease characteristics were consistently associated with vascular hemodynamic alterations in RA.
Allopurinol Use In Concomitant Gout and Diabetes Lowers Cardiovascular Event Risk
Study analyzes insurance claims data to examine the relationship between allopurinol use in patients with both gout and diabetes and its effect on cardiovascular event risk.
Corticosteroids Linked to Increased Metabolic Syndrome Risk
Researchers found a correlation between use of corticosteroids and increased odds of metabolic syndrome and elevated body mass index.
No Association Between Knee Osteoarthritis and Metabolic Syndrome
Study uses data from the Framingham Offspring Cohort to investigate possible relationships between knee osteoarthritis and components of the metabolic syndrome.
Next post in Osteoarthritis
